Federica Cuppone

2.1k total citations · 1 hit paper
50 papers, 1.5k citations indexed

About

Federica Cuppone is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Federica Cuppone has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 25 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Federica Cuppone's work include Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (19 papers) and Lung Cancer Treatments and Mutations (13 papers). Federica Cuppone is often cited by papers focused on Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (19 papers) and Lung Cancer Treatments and Mutations (13 papers). Federica Cuppone collaborates with scholars based in Italy, Malaysia and United States. Federica Cuppone's co-authors include Emilio Bria, Diana Giannarelli, Michèle Milella, Francesco Cognetti, E. Terzoli, Isabella Sperduti, Paolo Carlini, Cecilia Nisticò, Vanja Vaccaro and Giampaolo Tortora and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Federica Cuppone

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Luisa Carbognin, Sara Pilotto et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Cuppone Italy	20	1.1k	604	388	199	152	50	1.5k
А. Н. Махсон Russia	15	1.2k 1.1×	563 0.9×	397 1.0×	310 1.6×	93 0.6×	23	1.7k
Andrew Dean Australia	17	1.1k 1.0×	694 1.1×	267 0.7×	262 1.3×	124 0.8×	104	1.6k
James F. Huth United States	17	1.1k 1.0×	636 1.1×	550 1.4×	277 1.4×	131 0.9×	48	1.7k
Editta Baldini Italy	21	1.1k 1.0×	470 0.8×	513 1.3×	319 1.6×	59 0.4×	83	1.5k
A. Antón Spain	18	1.3k 1.1×	695 1.2×	492 1.3×	178 0.9×	96 0.6×	103	1.7k
Catharina Wenzel Austria	22	979 0.9×	376 0.6×	403 1.0×	221 1.1×	62 0.4×	48	1.4k
Tamer M. Fouad United States	19	683 0.6×	291 0.5×	425 1.1×	211 1.1×	135 0.9×	41	1.1k
Vicki L. Keedy United States	20	806 0.7×	766 1.3×	321 0.8×	518 2.6×	62 0.4×	77	1.5k
R. Largillier France	14	940 0.8×	334 0.6×	527 1.4×	162 0.8×	42 0.3×	47	1.5k
Elide Matano Italy	14	907 0.8×	863 1.4×	161 0.4×	228 1.1×	52 0.3×	48	1.5k

Countries citing papers authored by Federica Cuppone

Since Specialization

Citations

This map shows the geographic impact of Federica Cuppone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Cuppone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Cuppone more than expected).

Fields of papers citing papers by Federica Cuppone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Cuppone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Cuppone. The network helps show where Federica Cuppone may publish in the future.

Co-authorship network of co-authors of Federica Cuppone

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Cuppone. A scholar is included among the top collaborators of Federica Cuppone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Cuppone. Federica Cuppone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carbognin, Luisa, Sara Pilotto, Michèle Milella, et al.. (2015). Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers. PLoS ONE. 10(6). e0130142–e0130142. 375 indexed citations breakdown →

Milella, Michèle, Carmen Nuzzo, Emilio Bria, et al.. (2012). EGFR Molecular Profiling in Advanced NSCLC: A Prospective Phase II Study in Molecularly/Clinically Selected Patients Pretreated with Chemotherapy. Journal of Thoracic Oncology. 7(4). 672–680. 26 indexed citations

Loupakis, Fotios, Chiara Cremolini, Lisa Salvatore, et al.. (2011). Clinical impact of anti‐epidermal growth factor receptor monoclonal antibodies in first‐line treatment of metastatic colorectal cancer. Cancer. 118(6). 1523–1532. 29 indexed citations

Vaccaro, Vanja, Davide Melisi, Emilio Bria, et al.. (2011). Emerging pathways and future targets for the molecular therapy of pancreatic cancer. Expert Opinion on Therapeutic Targets. 15(10). 1183–1196. 44 indexed citations

Cuppone, Federica, Emilio Bria, Vanja Vaccaro, et al.. (2011). Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. Journal of Experimental & Clinical Cancer Research. 30(1). 54–54. 27 indexed citations

Bria, Emilio, Michèle Milella, Federica Cuppone, et al.. (2011). Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis. Annals of Oncology. 22(10). 2277–2285. 81 indexed citations

Bria, Emilio, Federica Cuppone, Diana Giannarelli, et al.. (2009). Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?. Cancer. 115(15). 3446–3456. 68 indexed citations

Cuppone, Federica, Emilio Bria, Paolo Carlini, et al.. (2008). Taxanes as primary chemotherapy for early breast cancer. Cancer. 113(2). 238–246. 47 indexed citations

Bria, Emilio, Richard J. Gralla, Harry Raftopoulos, et al.. (2008). Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: Meta-analysis of randomized clinical trials. Lung Cancer. 63(1). 50–57. 38 indexed citations

10.

Bria, Emilio, Federica Cuppone, Fabiana Letizia Cecere, et al.. (2007). Adjuvant Chemotherapy for Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(5). S7–S11. 12 indexed citations

11.

Cuppone, Federica, Emilio Bria, Sunil Verma, et al.. (2007). Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer. Cancer. 112(2). 260–267. 87 indexed citations

12.

Pace, Andrea, Cecilia Nisticò, Federica Cuppone, et al.. (2007). Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?. Clinical Breast Cancer. 7(7). 550–554. 35 indexed citations

13.

Carlini, Paolo, Emilio Bria, Diana Giannarelli, et al.. (2007). Aromatase inhibitors in post-menopausal metastatic breast carcinoma. Expert Opinion on Investigational Drugs. 16(7). 1023–1036. 3 indexed citations

14.

Bria, Emilio, Mariangela Ciccarese, Diana Giannarelli, et al.. (2006). Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: Pooled-analysis of 8794 patients. Cancer Treatment Reviews. 32(5). 325–332. 15 indexed citations

15.

Ferretti, G., Emilio Bria, Diana Giannarelli, et al.. (2006). Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?. CHEST Journal. 130(6). 1808–1816. 26 indexed citations

16.

Nisticò, Cecilia, Federica Cuppone, Emilio Bria, et al.. (2006). Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Anti-Cancer Drugs. 17(10). 1193–1200. 6 indexed citations

17.

Bria, Emilio, Federica Cuppone, Mariangela Ciccarese, et al.. (2006). Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials. Cancer Treatment Reviews. 32(8). 583–587. 52 indexed citations

18.

Bria, Emilio, A. Ceribelli, Marco Trovò, et al.. (2006). Non-small cell lung cancer: early stages. Annals of Oncology. 17. ii17–ii21. 2 indexed citations

19.

Nisticò, Cecilia, F. Cognetti, Luciano Frontini, et al.. (2005). Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study. Oncology. 68(4-6). 356–363. 9 indexed citations

20.

Bria, Emilio, Diana Giannarelli, Alessandra Felici, et al.. (2005). Taxanes with anthracyclines as first‐line chemotherapy for metastatic breast carcinoma. Cancer. 103(4). 672–679. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact